Collaborative clinical medicines procurement ccmp getting value for money
1 / 15

Collaborative Clinical Medicines Procurement CCMP Getting Value for Money - PowerPoint PPT Presentation

  • Uploaded on

Collaborative Clinical Medicines Procurement (CCMP) “Getting Value for Money”. Colette Whigham Category Manager – Pharmacy NHS National Procurement, Scotland Thursday 11 th November 2010. National Procurement.

I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
Download Presentation

PowerPoint Slideshow about 'Collaborative Clinical Medicines Procurement CCMP Getting Value for Money ' - george

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.

- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
Collaborative clinical medicines procurement ccmp getting value for money l.jpg

Collaborative Clinical Medicines Procurement (CCMP) “Getting Value for Money”

Colette Whigham

Category Manager – Pharmacy

NHS National Procurement, Scotland

Thursday 11th November 2010

National procurement l.jpg
National Procurement

Commenced activities in Scotland in 2005 following recommendations made by the McClelland review of public sector procurement.

Purchasing activities across the NHSS historically had been managed:-

In a sporadic manner

Limited coordination across NHS Scotland

Little aggregation of spend across NHS Scotland and more than 23 procurement organisations

Workstream activity redesign l.jpg
Workstream Activity Redesign

Maximise the potential savings by NHS Scotland by sharing the benefits of collaborative buying power. These are realised by the application of best practice strategic sourcing processes and working with suppliers to obtain best value products and services.

Strategic Sourcing

Simplify the physical supply chain using managed distribution systems to achieve economies of scale delivered from the National Distribution Centre. (Non Pharmaceuticals)


Coordinate the deployment of world class procurement technology across Health Boards. This offers users access to a variety of tools that support strategic and transactional procurement and enable new methods of collaboration.


Slide4 l.jpg

Scottish Pharmacologistics Governance Framework
























National contracting strategy for medicines l.jpg
National Contracting Strategy for Medicines

Key Elements:-

Procurement Regulations

Clinical Involvement

Specification Design

Contract Shape

Supplier Conditioning

Anticipated Outcomes


National contracting strategy for medicines6 l.jpg
National Contracting Strategy for Medicines

Key Features:-





Joined Up

Delivers Savings Consistently

Clinical Governance

Financial Governance

National contracting challenges l.jpg
National Contracting Challenges

Resistance to and fear of change

Lack of awareness of procurement regulations

Lack of understanding of market dynamics

Industry Resistance

Lack of clinical resource to implement change

It’s too


What’s in it for me?

It will take to long!

I don’t have


It’s too


It’s not my job!!

They won’t fund it

No one asked me

It’s too ambitious

We can’t take the chance

It’s impossible

We tried that before

It’s too


We’ve always done it this way!

We don’t have the staff

We are doing ok as it is!!

I’m all for it, but…

We’ve never done that before

It won’t work in this department

They really don’t want to change

There’s not enough time

It needs more thought

It’s not our problem!!

Clinical peer groups in scotland actively engaged with national procurement l.jpg
Clinical Peer Groups in Scotland actively engaged with National Procurement

Diabetes Action Plan – Scottish Government

Hepatitis C Action Plan – Scottish Government

Scottish HIV Action Group - Scottish Government

Scottish Antimicrobial Pharmacy Group

Scottish Radiological Society

Scottish Society for Rheumatology

Scottish Plasma Expert Panel

Scottish Haemophilia Directors

Scottish Cancer Networks

Scottish Fertility Group

Total Parenteral Nutrition Managed Clinical Network

Scottish Neonatal and Paediatric Pharmacists

Scottish Critical Care Pharmacy Group

Scottish Pharmacists Quality Assurance Group

Patient Access Scheme Advisory Group (PASAG)

Lessons learned l.jpg
Lessons Learned

Communication (Stakeholders and Industry)


Change for sake of change

Well developed specifications

Anticipate outcomes

Shared resource (Reduced representation at Clinical Level but endorsed nationally via peer groups)

Examples of successful collaborative clinical medicines procurement in scotland l.jpg
Examples of Successful Collaborative Clinical Medicines Procurement in Scotland

Low Molecular Weight Heparin – Product Standardisation

Hepatitis C Action Plan – Volume Matrix

Botulinum Toxin Type A – Clinical Substitution without rationalisation

IVF Fertility – Price Normalisation

Insulin Pumps – Ranked Framework

Clozapine – Single Supplier Framework

Homecare – Single Supplier Framework, HIV & Clotting Factors

Blood Glucose Monitoring Strips – Supplier Rationalisation

Contrast Media – Supplier Rationalisation, release market share

G-CSF – Scotland Wide Clinical Input

Gonadorelin Analogues - Clinical Substitution without rationalisation

Total Parenteral Nutrition

Erythropoetin Stimulating Agents

Transitional Medicines – Time to market, when is the right time?

Collaborative clinical medicines procurement getting value for money l.jpg
Collaborative Clinical Medicines Procurement “Getting Value for Money”

The Results:

2005/2006 = £4,721,238

2006/2007 = £8,953,191

2007/2008 = £5,873,646

2008/2009 = £5,128,995

2009/2010 = £5,713,346

Total Savings To Date = £   30,390,416

The future l.jpg
The Future… Value for Money”

More complex therapy areas (Work In Progress):

Continued Therapeutic Substitution




Closer collaborative working with Scottish Medicines Consortium (SMC)

Closer collaborative working with National/Health Board Formularies

Continued development of focused Clinical Advisory Panels

Summary l.jpg
Summary Value for Money”

No two procurement procedures are the same

Clinical input at the centre of all procurement activity

Savings are a key NHS agenda item

Change management, whilst challenging, is always possible

Future contracts will benefit from lessons learned

Procurement and Clinical resource is essential

Make a plan and stick to it!